KOL Call on LUMEVOQ® for the Treatment of Leber Hereditary Optic Neuropathy (LHON)

2020 ARVO Annual Meeting, Baltimore (MD), US – cancelled

2020 AAN Annual Meeting, Toronto, Canada – canceled due to COVID-19

GenSight Biologics on Track to Submit LUMEVOQ® for European Approval in September 2020 Following Pre-Submission Meeting with EMA

GenSight Biologics Announces Positive Data Safety Monitoring Board Review of PIONEER Phase I/II Trial of GS030 Combining Gene Therapy and Optogenetics for the Treatment of Retinitis Pigmentosa

GenSight Biologics Provides Update on Operations in the Context of COVID-19

GenSight Biologics announces presentation of bilateral visual recovery from GS010 (LUMEVOQ™) Phase III trials at the 46th annual meeting of NANOS

2020 Cell & Gene Meeting on the Mediterranean, Barcelona, Spain – cancelled

Bio Europe Spring, Paris, France

46th NANOS Annual Meeting, Amelia Island, Florida, US